Varun Jain, MD FACP

Hospitalist, Asst Prof UConn and Quinnipiac Univ, Cardio aspirant, Physician Coach, #QualityImprovement, Indian Air Force (Ex-Major)

[Dr.Hamad Aljarallah @hamad_jr7]

🧵The 2026 ACC/AHA Dyslipidemia Guidelines are officially out!
These new updates bring major shifts in risk assessment, novel lipid markers, and cholesterol targets.
Open access 🔓
https://t.co/NYwsuLQYYz
Here are the most salient features you need to know.👇

[Varun Jain, MD FACP @vjainmd]

A major trial we all awaited.

[I.H.Tanboga, MD, PhD @ihtanboga]

https://t.co/EK010QHWzh

[John Mandrola, MD @drjohnm]

You wish journal editorials were half this good

[Eric Topol @EricTopol]

New ACC/AHA Guidelines published today for lipids
address measuring Lp(a) and ApoB
https://t.co/jO8ZG7iltN

[Elon Musk @elonmusk]

There need to be prosecutions

[Varun Jain, MD FACP @vjainmd]

Is it time to start de-prescribing?

[JAMA Cardiology @JAMACardio]

Meta-analysis of four randomized trials found β-blockers did not reduce mortality, recurrent #MyocardialInfarction (MI), heart failure, or revascularization in patients with preserved left ventricular ejection fraction after MI. https://t.co/7Kht1Pi1QE

[JAMA Cardiology @JAMACardio]

Meta-analysis of four randomized trials found β-blockers did not reduce mortality, recurrent #MyocardialInfarction (MI), heart failure, or revascularization in patients with preserved left ventricular ejection fraction after MI. https://t.co/7Kht1Pi1QE

[Prof Chris P Gale @cpgale3]

Withdrawal of heart failure therapy after atrial fibrillation rhythm control with ejection fraction normalization: the WITHDRAW-AF trial https://t.co/MyFxT5VxcX

[Eric Topol @EricTopol]

The harmful and biased medical advice from social medial influencers, highlighting lack of expertise, and financial conflicts. Many specific examples and recommendations provided @bmj_latest
https://t.co/zFjaqQvi9O

[JAMA @JAMA_current]

Today, @WHO published a guideline in JAMA on the use and indications of #GLP1 therapies, including GLP-1 receptor agonists and GLP-1/GIP dual agonists, for the global treatment of #obesity in adults. https://t.co/mgaUmJUUxy 🧵

[EHJ Editor-in-Chief @ehj_ed]

Over the past two decades, the risk of stroke in atrial fibrillation patients decreased significantly among all age groups, with no subsequent increase in the risk of bleeding.
Read more in #EHJ
@escardio @ESC_Journals #atrialfibrillation

https://t.co/rAhd2bBlTH

[European Society of Cardiology Journals @ESC_Journals]

Cellular and molecular imaging of coronary atherosclerosis: clinical applications. A State-of-the-Art review just published in #EHJ 👉 https://t.co/iElnGXCyIN

@RoccoMontone @ehj_ed

[JAMA Cardiology @JAMACardio]

In older patients with myocardial infarction and multivessel disease, physiology-guided complete revascularization achieved a sustained reduction in adverse outcomes compared to culprit-only treatment over a 3-year follow-up period. https://t.co/kZUI2Dl9G4

[EHJ Editor-in-Chief @ehj_ed]

Urinary tract infection and continuation of sodium-glucose cotransporter-2 inhibitors in diabetic patients. Read more in EHJ.
https://t.co/bK3nceAi08

@ESCardio @ESC_Journals #DiabetesCare #UTI #SGLT2Inhibitors #SGLTi

[JAMA @JAMA_current]

New blood pressure guidelines from @American_Heart and @ACCinTouch emphasize earlier treatment and tighter control.

Learn what’s new—and what remains unchanged—in the latest recommendations. #hypertension

https://t.co/PquihlJv2D

[Abdulla A. Damluji, MD, PhD @DrDamluji]

Acute coronary syndromes: mechanisms, challenges, and new opportunities: @ESC_Journals

🥸Very nice review -

😱Many research questions

👇👇👇

[UC San Diego Cardiology Fellows @UCSDCardFellows]

🧵A Fellow’s Guide to Impella

MCS can feel like alphabet soup: IABP, Impella CP/5.5, ECMO, RP Flex, Tandem. But behind the wires and waveforms is a real framework.

Here’s a breakdown from a phenomenal teaching session by @QuanBuiMD #UCSDlifer

[Varun Jain, MD FACP @vjainmd]

It was a wonderful conference! A big shout out to @SDRoyMD for his mentorship and commitment to personal growth. #cvi2025

[Shubha Deep Roy, MD, FACC, FASE, FASNC, FSCAI @SDRoyMD]

Enjoyed and learnt every minute at @cvinnovations CVI2025. Thanks to course directors Drs. Subhash Banerjee, @esbrilakis @psorajja @shishem for organizing such a fantastic conference. Great work by @vjainmd presenting our challenging case.
Looking forward to attending again next year!

[The Heart @ZHeart11768530]

🔴European guidelines for hypertension in 2024: a comparison of key recommendations for clinical practice⤵️
🔬 2025 Expert Recommendation @NatRevCardiol

🔹https://t.co/zlIlT0j2WB
#MedEd #MedX #Diagnosis
#Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd

[Varun Jain, MD FACP @vjainmd]

Off to a great start for the 10th Annual Cardiology Boot Camp 101! In-depth and practical series of lectures by amazing faculty! Look forward to the next week. #cardiocurious #Cardiology @SrihariNaiduMD @SDRoyMD @zoll_cms